Early Mixed Chimerism Does Not Alter Long-Term Prognosis for Patients Receiving IV Busulfan-Fludarabine (Iv Bu-Flu) With Allogeneic Stem Cell Transplantation for AML/MDS

✍ Scribed by X. Tang; M. de Lima; W. Wei; A. Chiattone; P.F. Thall; L.J. Medeiros; G. Rondon; E.J. Shpall; R.B. Jones; Y. Nieto; A. Alousi; R.E. Champlin; B.S. Andersson

• Book ID: 116282385
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 67 KB
• Volume: 17
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2010.12.449